Gait disturbances are associated with increased cognitive impairment and cerebrospinal fluid tau levels in a memory clinic cohort

Manuscript Number: 

20-0225R1

Author(s): 
Marie Bruun, Kristian Steen Frederiksen, Merja Hallikainen, Steen Gregers Hasselbalch, Sanna-Kaisa Herukka, Jyrki Lötjönen, Jussi Mattila, Marijn Muurling, Juha Pärkkä, Hanneke FM Rhodius-Meester, Philip Scheltens, Hilkka Soininen, Charlotte E. Teunissen, Pieter Jelle Visser, Casper de Boer, Mark van Gils, Wiesje M. van der Flier

Disclosures

Marie Bruun

  • Nothing to Disclose

Casper de Boer

  • Nothing to Disclose

Kristian Steen Frederiksen

  • Nothing to Disclose

Merja Hallikainen

  • Nothing to Disclose

Steen Gregers Hasselbalch

  • Nothing to Disclose

Sanna-Kaisa Herukka

  • Nothing to Disclose

Jyrki Lötjönen

  • Equity:
    Shareholder and founder in Combinostics Oy
    Lecture Fees:
    Lecture fees from Merck and Sanofi, paid to Combinostics Oy.
    Patents/Royalties
    Inventor in 8 patents but none is related to this work.

Jussi Mattila

  • Equity:
    Shareholder and founder in Combinostics Oy.
    Patents/Royalties
    Inventor in patents but none of them is related to this work.

Marijn Muurling

  • Nothing to Disclose

Juha Pärkkä

  • Nothing to Disclose

Hanneke FM Rhodius-Meester

  • Patents/Royalties
    Hanneke FM Rhodius- Meester performs contract research for Combinostics, all funding is paid to her institution.

Philip Scheltens

  • Nothing to Disclose

Hilkka Soininen

  • Consulting Fees:
    Fees for advisory boards of ACImmune, MERCK and Novo Nordisk.

Charlotte E. Teunissen

  • Consulting Fees:
    Advisory Board for Roche
    Lecture Fees:
    Roche, lecture fee.

Wiesje M. van der Flier

  • Lecture Fees:
    Biogen; all funding paid to institution
    Grants
    • Agency: 
      Combinostics
      Dates: 
      2018

Mark van Gils

  • Nothing to Disclose

Pieter Jelle Visser

  • Nothing to Disclose